pills

Medical Devices DECODED

Previous edition: 08 Apr 2024
Share article

Get the full version straight to your inbox.
Exclusive access to our best-in-class data & intelligence
Subscribe now

BD launches new spectral cell sorters for cell biology and immunology

The BD FACSDiscover S8 Cell Sorters are designed to offer real-time imaging and spectral flow cytometry capabilities.

Becton, Dickinson and Company (BD) has announced the commercial release of the BD FACSDiscover S8 Cell Sorters worldwide, expanding research tool access in cell biology, cancer research, and immunology.

Featuring BD CellView Image Technology and BD SpectralFX Technology, the new spectral cell sorters are designed to offer real-time imaging and spectral flow cytometry capabilities.

BD said the BD CellView Image Technology enhances the quality of sorts and samples, providing confidence in biological results and efficiency in downstream applications.

European Molecular Biology Laboratory (EMBL) research staff scientist Daniel Schraivogel said: “For my research in cellular biology, the instrument was perfectly configured when it came to the number of lasers and imaging capabilities.

“It has the same sorting speed and software capabilities as the five-laser unit, making experiments extremely scalable on an easy-to-use instrument.”

The BD FACSDiscover S8 Cell Sorters allow researchers to gain complex biological and spatial insights, capture individual cell images, and isolate desired cells, based on visual characteristics at high speeds.

The three and four-laser models of the BD FACSDiscover S8 Cell Sorter family complement the previously launched five-laser instrument, offering scientists more options and flexibility.

Schraivogel added: “In addition to the added value of spatial information that is needed for many projects in cell biology, infection biology and functional genomic screening, the imaging sorter allows us to better explore our cell populations and is used to validate true single-cell gating and sorting, to deliver better-quality cells and biological outputs.”

Last month, BD and Poland’s non-governmental non-profit organisation The Great Orchestra of Christmas Charity (GOCC) teamed up to expand testing for bloodstream infections (BSIs) and sepsis management in the country.

Latest news

J&J seeks cardiovascular market growth with $13.1bn Shockwave deal

The deal expands J&J's footprint in coronary artery disease and peripheral artery disease treatment devices.

Omron announces acquisition of Dutch Luscii Healthtech

The acquisition will give the Japanese medtech firm a greater foothold in the European market taking over an app already present in 70% of Dutch hospitals.

Oasis introduces punctal plug for dry eye treatment

The SOFT PLUG Extended Duration 180-T Tapered Plug features a 0.25mm tapered end.

LMI and SOFIE to launch Neuraceq PET imaging agent in Cleveland, US

The Neuraceq imaging agent for beta-amyloid PET scans will be distributed from SOFIE's site in Cleveland, Ohio.

“New frontier” for xenotransplantation as pig kidney patient leaves hospital

Xenotransplantation is said to be "on the brink of a monumental breakthrough" following the successful operation.

Clarius and ThinkSono launch AI-guided ultrasound system in Europe

The companies are also preparing for a FDA submission for the AI-guided ultrasound system.

Pfizer's Velsipity UK approval will raise competition in ulcerative colitis market, says GlobalData

As Pfizer further expands its portfolio in the treatment of UC, the competition in the market increases.

Pfizer’s Velsipity UK approval will raise competition in ulcerative colitis market, says GlobalData

Pfizer’s oral drug, Velsipity (etrasimod), recently received approval from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). With this approval, the drug will increase the competition in the UC market.

Find out more

In our previous edition

Newsletters in other sectors

Explore our market-leading Intelligence Centers

Still looking?

Search companies, themes, reports, as well as actionable data & insights spanning 22 global industries

Explorer

Access more premium companies when you subscribe to Explorer